Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Biosimilares

Research Grade Ranibizumab (HB941016)

Research Grade Ranibizumab
Research Grade Ranibizumab
Research Grade Ranibizumab
Research Grade Ranibizumab
Precio(USD): $
Especificación:
  • 100ug
  • 1mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

Vista general
Número de catálogoHB941016
Descripción
Ranibizumab (HB941016) is a research-grade recombinant antibody targeting Vascular endothelial growth factor A. Produced in mammalian cells with native-like glycosylation.
Highlights
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especiesHuman
AplicacionesELISA, Bioactivity: FACS, Functional assay, Research in vivo
Especie huéspedHumanized
IsotipoFab-G1-kappa
Sistema de expresión Mammalian Cells
Clonalidad Monoclonal
Objetivo Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
Nivel de endotoxinas Please contact the lab for this information.
Pureza >95% purity as determined by SDS-PAGE.
Purificación Protein L purified from cell culture supernatant.
Número de acceso P15692
Forma Liquid
Buffer de almacenamiento 0.01M PBS, pH 7.4.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Nombres alternativosFab-12variantY0317, RhuFab, 347396-82-1
Fondo

Vascular endothelial growth factor A, long form (VEGFA) is a ~43 kDa protein. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A. Involved in protecting cells from hypoxia-mediated cell death. VEGFA is the therapeutic target of bevacizumab (Avastin).

1. Katsman, M. et al. (2022) Cells 11. PMID: 35455969
Nota For research use only. Not suitable for clinical or therapeutic use.
Imágenes
  • Research Grade Ranibizumab

    Bioactivity

    Detects Human VEGFA in indirect ELISAs.

  • Research Grade Ranibizumab

    SDS-PAGE

    SDS-PAGE for Research Grade Ranibizumab.

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: support@abinScience.com

Lista de distribuidores